Banco Santander S.A. (SAN)
Vienna Stock Exchange · Austria · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 11.24 |
|---|---|
| 52-week range | 8.30 – 13.09 |
| Return, 1 month / 3 months | −11.2% / −8.4% |
| Return, 1 year / 3 years | +34.9% / +270.5% |
| Trend | Below its 200-day average |
| RSI (14) | 32 |
| Volatility (1 year) | 32.9% |
| Worst drawdown (1 year) | -17.6% |
| Average daily value traded | 0.02M EUR |
| Dividend yield | 2.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Banco Santander is a banking group based in Spain that serves individual customers, small businesses and large companies. It offers current and savings accounts, mortgages, consumer loans, credit cards, insurance and investment products through its branch networks and digital channels. The group also provides corporate and investment banking, including lending, trade finance and treasury services, to business clients. Its retail and commercial banking operations span several European countries and the Americas.
The shares are listed on the Vienna Stock Exchange in Austria under the code SAN, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Banco Santander S.A. (SAN) trades on the Vienna Stock Exchange in Austria. It last closed at EUR 11.24 on 27 October 2026.
Its price-based Market X-Ray is 57 out of 100 (a fair price profile), ranking 31 of 84 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 34.9% and over the last three months it fell 8.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Vienna Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 59 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 0.0% | ||
| From 52-week high | -13.8% | ||
| Momentum | 59 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -8.4% | ||
| 6-month return | 10.9% | ||
| 12-month return, skipping the last month | 52.0% | ||
| Stability (higher is calmer) | 57 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 32.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -17.6% | ||
| Liquidity | 45 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.02M EUR | ||
| Zero-volume days | 1.7% | ||
| Income | 64 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.1% | ||
| Years with dividends | 6 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −3.7% |
|---|---|
| 1 month | −11.2% |
| 3 months | −8.4% |
| 6 months | +10.9% |
| 1 year | +34.9% |
| 3 years | +270.5% |
| 5 years | +314.6% |
Signals
| 50-day / 200-day average | 12.40 / 11.24 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.24 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 30 Apr 2026 | EUR 0.1250 |
| 30 Oct 2025 | EUR 0.1150 |
| 29 Apr 2025 | EUR 0.1100 |
| 30 Oct 2024 | EUR 0.1000 |
| 29 Apr 2024 | EUR 0.0950 |
| 31 Oct 2023 | EUR 0.0810 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Vienna Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.